Combination Treatment for Nicotine Dependence: State of the Science

References

• Ahmadi J., Ashkani H., Ahmadi M., Ahmadi N. Twenty-four week maintenance treatment of cigarette smoking with nicotine gum, clonidine and naltrexone. Journal of Substance Abuse Treatment 2003; 24: 251–255, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Balfour D. J. The pharmacology underlying pharmacotherapy for tobacco dependence: A focus on bupropion. International Journal of Clinical Practice 2001; 55: 53–57, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Benowitz N. L. The biology of nicotine dependence; from the 1988 Surgeon General's Report to the present and into the future. Nicotine & Tobacco Research 1999; 1: S159–S163, [INFOTRIEVE]
   Google Scholar
• Biberman R., Neumann R., Katzir I., Gerber Y. A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation. Addiction 2003; 98: 1403–1407, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Blondal T., Gudmundsson L. J., Tomasson K., Jonsdottir D., Hilmarsdottir H., Kristjansson F., Nilsson F., Bjornsdottir U. S. The effects of fluoxetine combined with nicotine inhalers in smoking cessation—a randomized trial. Addiction 1999; 94: 1007–1015, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bohadana A., Nilsson F., Rasmussen K., Mayo M. S. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Archives of Internal Medicine 2000; 160: 3128–3134, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Burton S. L., Gitman J. G., Shiffman S. Epidemiology Branch, National Center for Chronic Disease Prevention and Health Promotion, CDC. Use of FDA-approved pharmacologic treatments for tobacco dependence—United States, 1984–1998. MMWR 2000; 49: 665–668
   PubMedGoogle Scholar
• Covey L. S., Glassman A. H., Stetner F., Rivelli S., Stage K. A randomized trial of sertraline as a cessation aid for smokers with a history of major depression. The American Journal of Psychiatry 2003; 159: 1731–1737, [CROSSREF]
   Google Scholar
• Croghan G. A., Sloan J. A., Croghan I. T., Novotny P., Hurt R., DeKrey W. L., Mailliard J. A., Ebbert L. P., Swan D. K., Walsh D. J., Wiesenfeld M., Levitt R., Stella P., Johnson P. A., Tschetter L. K., Lprinzi C. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: A minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine & Tobacco Research 2003; 5: 181–187, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• da Costa C. L., Younes R. N., Lourenco M. T. C. Stopping smoking: A prospective, randomized, double-blind study comparing nortriptyline to placebo. Chest 2002; 122: 403–408, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• DeGraff A. C., Jr. Pharmacologic therapy for nicotine addiction. Chest 2002; 122: 392–394, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Department of Health and Human Services, Public Health Service. The Health Consequences of Smoking: Nicotine Addiction. A report of the Surgeon General, DHHS, (CDC) Publication No. 88-8406, Government Printing Office, Washington, DC 1988
   Google Scholar
• Etter J. -F., Laszlo E., Zellweger J -P., Perrot C., Perneger T. V. Nicotine replacement to reduce cigarette consumption in smokers who are unwilling to quit: A randomized trial. Journal of Clinical Psychopharmacology 2002; 22: 487–494, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Etter J -F., le Houezec J., Landfeldt B. Impact of messages on comcomitant use of nicotine replacement therapy and cigarettes: A randomized trial on the Internet. Addiction 2003; 98: 941–950, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Fiore M. C., Bailey W. C., Cohen S. J., et al. Treating tobacco use and dependence. AHQR publication No. 00-0032. US Department of Health and Human Services, Public Health Service, Rockville, MD 2000
   Google Scholar
• Gold M. S., Herkov M. J. Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse. Journal of Addictive Diseases 1998; 17: 7–21, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gourlay S. G., Benowitz N. L. Is clonidine an effective smoking cessation therapy?. Drugs 1995; 50: 197–207, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hall S. M., Reus V. I., Munoz R. F., Sees K. L., Humfleet G., Hartz D. T., Frederick S., Triffleman E. Nortriptyline and cognitive behavioral therapy in the treatment of cigarette smoking. Archives of General Psychiatry 1998; 55: 683–690, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Haustein K. O. Bupropion: Pharmacological and clinical profile in smoking cessation. International Journal of Clinical Pharmacology and Therapeutics 2003; 41: 56–66, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hays J. T., Ebbert J. O. Bupropion for the treatment of tobacco dependence. Guidelines for balancing risks and benefits. CNS Drugs 2003; 17: 71–83, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hays J., Taylor M. D. Tobacco dependence treatment in patients with heart and lung disease: Implications for intervention and review of pharmacological therapy. Journal of Cardiopulmonary Rehabilitation 2000; 20: 215–223, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Hitsman B., Spring B., Borrelli B., Niaura R., Papandonatos G. D. Influence of antidepressant pharmacotherapy on behavioral treatment adherence and smoking cessation outcome in a combined treatment involving fluoxetine. Experimental and Clinical Psychopharmacology 2001; 9: 355–362, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Holm K., Spencer C. M. Bupropion: A review of its use in the management of smoking cessation. Drugs 2000; 59: 1007–1024, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hughes J. R., Goldstein M. C., Hurt R. D., Shiffman S. Recent advances in the pharmacotherapy of smoking. Journal of the American Medical Association 1999; 281: 72–76, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hughes J. R., Keely J. P., Niaura R. S., Ossip-Klein D. J., Richmond R. L., Swan G. E. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research 2003; 5: 13–26, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hurt R. D., Krook J. E., Craghan I. T., Loprinzi C. L., Sloan J. A., Novotny P. J., Kardinal C. G., Knost J. A., Tirona M. R., Addo F., Morton R. F., Michalak J. C., Schaefer P. L., Porter P. A., Stella P. J. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. Journal of Clinical Oncology 2003; 21: 914–920, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jamerson B. D., Nides M., Jorenby D. E., Donahue R., Garrett P., Johnston J. A., Fiore M. C., Rennard S. I., Leischow S. J. Late-term smoking cessation despite initial failure: An evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo. Clinical Therapeutics 2001; 23: 744–752, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jorenby D. E. Clinical efficacy of bupropion in the management of smoking cessation. Drugs 2002; 62: 25–35, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jorenby D. E., Leischow S. J., Nides M. A., Rennard S. I., Johnston J. A., Hughes A. R., Smith S. S., Muramoto M. L., Daughton D. M., Doan K., Fiore M. C., Baker T. B. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine 2003; 340: 685–691, [CROSSREF]
   Google Scholar
• Karnath B. Smoking cessation. American Journal of Medicine 2002; 112: 399–405, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Killen J. D., Fortmann S. P., Schatzberg A. F., Hayward C., Sussman L., Rothman M., Strausberg L., Varady A. Nicotine patch and paroxetine for smoking cessation. Journal of Consulting and Clinical Psychology 2000; 68: 883–889, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Koren G. Nicotine replacement therapy during pregnancy. Canadian Family Physician 2001; 47: 1971–1972, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Macleod Z. R., Charles M. A., Arnaldi V. C., Adams I. M. Telephone counselling as an adjunct to nicotine patches in smoking cessation: A randomised controlled trial. Medical Journal of Australia 2003; 179: 349–352, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Molyneux A., Lewis S., Leivers U., Anderton A., Antoniak M., Brackenridge A., Nilsson F., McNeill A., West R., Moxham J., Britton J. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003; 58: 484–488, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nardini S. Smoking cessation: The role of Bupropion among new pharmacologic agents. Monaldi Archive for Chest Diseases 2001; 56: 467–472
   PubMedGoogle Scholar
• Okuyemi K. S., Ahluwalia J. S., Harris K. J. Pharmacotherapy of smoking cessation. Archives of Family Medicine 2000; 9: 270–281, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Oncken C. A., Kranzler H. R. Pharmacotherapies to enhance smoking cessation during pregnancy. Drug & Alcohol Review 2003; 22: 191–202, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Peters M. J., Morgan L. C. The pharmacotherapy of smoking cessation. Medical Journal of Australia 2002; 176: 486–490, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Picciotto M. R. Common aspects of the action of nicotine and other drugs of abuse. Drug and Alcohol Dependence 1998; 51: 165–172, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pierce J. P., Gilpin E. A. A minimum 6-month prolonged abstinence should be required for evaluation smoking cessation trials. Nicotine & Tobacco Research 2003; 5: 151–153, [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Prochazka A. V., Weaver M. J., Keller R. T., Freyer G. E., Licari P. A., Lofaso D. A randomized trial of nortriptyline for smoking cessation. Archives of Internal Medicine 1998; 158: 2035–2039, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Richmond R. L., Harris K., de Almeida Neto A. The transdermal nicotine patch: Results of a randomised placebo-controlled trial. The Medical Journal of Australia 1994; 161: 130–135, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Richmond R. L., Kehoe L., Almeida Neto A. C. Effectiveness of a 24-hour transdermal nicotine patch in conjunction with a cognitive behavioural programme: One year outcome. Addiction 1997; 92: 27–31, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Richmond R., Zwar N. Review of bupropion for smoking cessation. Drug & Alcohol Review 2003; 22: 203–220, [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Rollnick S., Mason P., Butler C. Health Behavior Change. Churchill Livingstone, London 1999
   Google Scholar
• Rolnick S. J., Klevan D., Cherney L., Lando H. Nicotine replacement therapy in a group model HMO. HMO Practice 1997; 11: 34–37, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Rose J. E., Behm F. M., Westman E. C. Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy. Experimental and Clinical Psychopharmacology 1998; 6: 331–343, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Schauffler H. H., Mordawsky J. K., McMenamin S. Adoption of the AHCPR Clinical Practice Guideline for Smoking Cessation: A Survey of California's HMOs. American Journal of Preventive Medicine 2001; 21: 153–161, [CROSSREF]
   PubMedGoogle Scholar
• Shoptaw S., Rotheram-Fuller E., Yang X., Frosch D., Nahom D., Jarvik M. E., Rawson R. A., Ling W. Smoking cessation in methadone maintenance. Addiction 2002; 97: 1317–1328, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Silagy C., Lancaster T., Stead L. F., Mant D., Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database System Review 2002; 4
   Google Scholar
• Simon J. A., Carmody T. P., Hudes E. S., Snyder E., Murray J. Intensive smoking cessation counseling versus minimal counseling among hospitalized smokers treated with transdermal nicotine replacement: A randomized trial. American Journal of Medicine 2003; 114: 555–562, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sims T. H., Fiore M. C. Pharmacotherapy for treating tobacco dependence: What is the ideal duration of therapy?. CNS Drugs 2002; 16: 653–662, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Steele C. Zyban: An effective treatment for nicotine addiction. Hospital Medicine 2000; 61: 785–788, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Swan G. E., McAfee T., Curry S. J., Jack L. M., Javitz H., Dacey S., Bergman K. Effectiveness of bupropion sustained release for smoking cessation in a health care setting: A randomized trial. Archives of Internal Medicine 2003; 163: 2337–2344, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Swanson N. A., Burroughs C. C., Long M. A., Lee R. W. Controlled trial for smoking cessation in a Navy shipboard population using nicotine patch, sustained-release bupropion, or both. Military Medicine 2003; 168: 830–834, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Tønnesen P., Tonstad S., Hjalmarson A., Lebargy F., van Spiegel P. I., Hider A., Sweet R., Townsend J. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. Journal of Internal Medicine 2003; 254: 184–192, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Thomson C. C., Rigotti N. A. Hospital-and clinic-based smoking cessation interventions for smokers with cardiovascular disease. Progressive Cardiovascular Disease 2003; 45: 459–479, [CROSSREF]
   PubMedGoogle Scholar
• Wagena E. J., Zeegers M. P., van Schayck C. P., Wouters E. F. Benefits and risks of pharmacological smoking cessation therapies in chronic obstructive pulmonary disease. Drug Safety 2003; 26: 381–403, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Watts S. A., Noble S. L., Smith P. O., Disco M. First-line pharmacotherapy for tobacco use and dependence. Journal of the American Board of Family Practice 2002; 15: 489–497, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wennike P., Danielsson T., Landfeldt B., Westin A., Tønnesen P. Smoking reduction promotes smoking cessation: Results from a double blind, randomized, placebo-controlled trial of nicotine gum with 2-year follow-up. Addiction 2003; 98: 1395–1402, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wiggers L. C., Smets E. M., de Haes J. C., Peters R. J., Legemate D. A. Smoking cessation interventions in cardiovascular patients. European Journal of Vascular & Endovascular Surgery 2003; 26: 467–475, [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. World Health Organization, Geneva 2002
   Google Scholar